SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-25-003878 to Tenon Medical, Inc. (TNON)

Tenon Medical, Inc.
Date: April 11, 2025 · CIK: 0001560293 · Accession: 0000000000-25-003878

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-286387

Date
April 11, 2025
Author
Division of
Form
UPLOAD
Company
Tenon Medical, Inc.

Letter

Re: Tenon Medical, Inc. Registration Statement on Form S-1 Filed April 4, 2025 File No. 333-286387 Dear Steven Foster:

April 11, 2025

Steven Foster Chief Executive Officer and President Tenon Medical, Inc. 104 Cooper Court Los Gatos, CA 95032

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Nicholas O'Leary at 202-551-4451 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: Jeffrey P. Wofford, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 April 11, 2025

Steven Foster
Chief Executive Officer and President
Tenon Medical, Inc.
104 Cooper Court
Los Gatos, CA 95032

 Re: Tenon Medical, Inc.
 Registration Statement on Form S-1
 Filed April 4, 2025
 File No. 333-286387
Dear Steven Foster:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Nicholas O'Leary at 202-551-4451 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Industrial
Applications and
 Services
cc: Jeffrey P. Wofford, Esq.
</TEXT>
</DOCUMENT>